MAYZENT
Active substance: siponimod
TABLET, FILM COATED · SIPONIMOD .25 mg/1
United StatesActive
Marketing holder: Novartis Pharmaceuticals Corporation
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
Composition
- SIPONIMOD · .25 mg/1
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| EU 1 |
|
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-45c6-79dc-9ada-277a1ccb0731,01a12093-3c19-7aaf-81e9-9308a5314e28,01a12093-424b-7945-a17d-718157d63415,01a12097-eeb9-7318-85e0-7efb7c74fcb8,01a1209a-b893-792c-81eb-205207f3a52d;count=6 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 0078-0979
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 0078-0979 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 0078-0979 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 0078-0979 · Verified 2026-10-09 · open in source